Wikidata

(Q38394502)

English

Adjuvant low-dose interleukin-2 (IL-2) plus interferon-α (IFN-α) in operable renal cell carcinoma (RCC): a phase III, randomized, multicentre trial of the Italian Oncology Group for Clinical Research (GOIRC).

scientific article

In more languages

Statements

title
Adjuvant low-dose interleukin-2 (IL-2) plus interferon-α (IFN-α) in operable renal cell carcinoma (RCC): a phase III, randomized, multicentre trial of the Italian Oncology Group for Clinical Research (GOIRC) (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25304727
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25304727%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 February 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q38394502&oldid=1787155891"